Literature DB >> 105148

Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals.

H Tatsumi, H Senda, S Yatera, Y Takemoto, M Yamayoshi, K Ohnishi.   

Abstract

Pipemidic acid (PPA) orally given in a dose of 100 mg/kg/day or more was found to cause lame gait in immature beagle dogs of about 3 months old. Their diarthrodial joints were abnormal with increased synovial fluid and blister formation under the outer layer of the articular cartilage. However, such an abnormality was not found in dogs younger than 2 weeks or older than 12 months. The blisters were formed at the joint areas bearing the body weight at a time when PPA was considered to be present there. Nalidixic and piromidic acids, structural analogues of PPA, also caused abnormality similar to PPA. The severity of the arthropathy was slight with piromidic acid as compared with PPA and nalidixic acid. The gait abnormality was almost disappeared spontaneously even if medication was continued. The incidence of the arthropathy was not or rarely observed in any young rats, rabbits and monkeys.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 105148     DOI: 10.2131/jts.3.357

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  16 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Authors:  G Hayem; C Carbon
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations.

Authors:  R Stahlmann; H J Merker; N Hinz; I Chahoud; J Webb; W Heger; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 4.  Quinolones in children. Are concerns over arthropathy justified?

Authors:  R Stahlmann; C Förster; D Van Sickle
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

5.  The effects of ciprofloxacin on human chondrocytes in cell culture.

Authors:  M A Mont; S K Mathur; C G Frondoza; D S Hungerford
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

6.  Parenteral fluoroquinolones in children with life-threatening infections.

Authors:  R Dagan; F Schlaeffer; M Einhorn
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

Review 7.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

8.  The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model.

Authors:  Jason M Sansone; Norman J Wilsman; Ellen M Leiferman; James Conway; Paul Hutson; Kenneth J Noonan
Journal:  J Pediatr Orthop       Date:  2009-03       Impact factor: 2.324

9.  Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo.

Authors:  M Kato; S Takada; S Ogawara; S Takayama
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy.

Authors:  R Stahlmann; C Förster; M Shakibaei; J Vormann; T Günther; H J Merker
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.